160 Health International Limited (HKG:2656)

160 Health International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	426.97	398.81	58.27	57.56	37.75
Cash & Short-Term Investments	426.97	398.81	58.27	57.56	37.75
Cash Growth	539.41%	584.46%	1.23%	52.47%	-
Accounts Receivable	265.67	203.89	170.67	117.82	63.59
Other Receivables	-	2.44	6.49	1.91	3.25
Receivables	265.67	206.33	177.16	119.73	66.84
Inventory	1.44	77.03	5.04	7.29	16.06
Prepaid Expenses	-	16.84	13.43	10.69	10.59
Restricted Cash	10.18	19.54	7.78	0.49	4.03
Other Current Assets	96.72	7.03	11.91	10.03	20.89
Total Current Assets	800.98	725.58	273.58	205.78	156.14
Property, Plant & Equipment	10.9	9.76	20.93	27.11	19.4
Long-Term Investments	32.8	14.6	-	-	-
Goodwill	-	0.1	0.1	0.1	0.1
Other Intangible Assets	1.11	1.25	1.74	2.23	2.7
Long-Term Deferred Tax Assets	6.15	6.12	1.21	0.83	-
Other Long-Term Assets	0.2	2.52	0.22	0.12	0.58
Total Assets	852.14	759.93	297.77	236.17	178.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	133.69	120.58	102.63	96.38	56.16
Accrued Expenses	83.31	86.23	112.25	73.31	83.25
Current Portion of Long-Term Debt	320.87	238.11	89.39	9.51	19.56
Current Portion of Leases	5.72	5.31	7.12	5.65	8.25
Current Income Taxes Payable	0.01	0.53	0.41	0.12	-
Current Unearned Revenue	48.22	58.34	45.09	43.43	39.77
Other Current Liabilities	-	7.62	14.37	24.86	337.12
Total Current Liabilities	591.82	516.73	371.26	253.25	544.1
Long-Term Debt	20	2.91	1.28	0.49	1.5
Long-Term Leases	1.32	3.53	11.88	17.01	6.02
Long-Term Unearned Revenue	5.23	2.64	1.86	5.97	19.73
Total Liabilities	618.37	525.81	386.28	276.72	571.36

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	0	0	0	0	58.19
Additional Paid-In Capital	935.5	935.5	595.47	595.47	374.81
Retained Earnings	-1,035	-1,037	-964.42	-856.73	-747.92
Treasury Stock	-	-1.77	-1.77	-1.77	-245.4
Comprehensive Income & Other	338.9	342.7	285.59	225.29	176.29
Total Common Equity	239.14	239.03	-85.14	-37.75	-384.02
Minority Interest	-5.38	-4.91	-3.37	-2.81	-8.41
Shareholders' Equity	233.76	234.11	-88.5	-40.56	-392.43
Total Liabilities & Equity	852.14	759.93	297.77	236.17	178.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	347.91	249.86	109.67	32.66	35.33
Net Cash (Debt)	79.06	148.94	-51.41	24.89	2.42
Net Cash Growth	-	-	-	928.64%	-
Net Cash Per Share	0.26	0.49	-0.17	0.09	0.01
Filing Date Shares Outstanding	336.45	336.45	302.81	290.53	285.64
Total Common Shares Outstanding	336.45	336.45	302.81	290.53	285.64
Working Capital	209.16	208.86	-97.67	-47.47	-387.96
Book Value Per Share	0.71	0.71	-0.28	-0.13	-1.34
Tangible Book Value	238.03	237.68	-86.97	-40.07	-386.82
Tangible Book Value Per Share	0.71	0.71	-0.29	-0.14	-1.35
Machinery	-	17.37	17.34	17.46	16.76
Leasehold Improvements	-	6.34	5.07	4.38	3.78

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error